JP2009511014A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009511014A5 JP2009511014A5 JP2008534644A JP2008534644A JP2009511014A5 JP 2009511014 A5 JP2009511014 A5 JP 2009511014A5 JP 2008534644 A JP2008534644 A JP 2008534644A JP 2008534644 A JP2008534644 A JP 2008534644A JP 2009511014 A5 JP2009511014 A5 JP 2009511014A5
- Authority
- JP
- Japan
- Prior art keywords
- self
- vector
- enhancer
- composition
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72420305P | 2005-10-05 | 2005-10-05 | |
| PCT/US2006/038776 WO2007044394A2 (en) | 2005-10-05 | 2006-10-04 | Compositions and methods for treatment of autoimmune disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009511014A JP2009511014A (ja) | 2009-03-19 |
| JP2009511014A5 true JP2009511014A5 (https=) | 2010-12-16 |
Family
ID=37943343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008534644A Pending JP2009511014A (ja) | 2005-10-05 | 2006-10-04 | 自己免疫疾患の処置のための組成物および方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100160415A1 (https=) |
| EP (1) | EP1931390B1 (https=) |
| JP (1) | JP2009511014A (https=) |
| CN (1) | CN101365494A (https=) |
| AU (1) | AU2006302477A1 (https=) |
| CA (1) | CA2624615A1 (https=) |
| IL (1) | IL190520A0 (https=) |
| NZ (1) | NZ567150A (https=) |
| WO (1) | WO2007044394A2 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2540085C (en) | 2003-09-29 | 2010-11-16 | Bruce Michael Koivisto | High alcohol content gel-like and foaming compositions |
| DE102004062775A1 (de) | 2004-12-21 | 2006-06-29 | Stockhausen Gmbh | Alkoholischer Pumpschaum |
| CN103417388A (zh) | 2005-03-07 | 2013-12-04 | 戴博全球保健有限公司 | 含有有机硅表面活性剂的高醇含量发泡组合物 |
| WO2010151420A1 (en) * | 2009-06-05 | 2010-12-29 | Bayhill Therapeutics, Inc. | Compositions and methods for treatment of insulin-dependent diabetes mellitus |
| WO2011091138A1 (en) * | 2010-01-20 | 2011-07-28 | Bayhill Therapeutics, Inc. | Combination therapy to treat autoimmune diseases |
| US9222107B2 (en) | 2011-05-25 | 2015-12-29 | National University Corporation Okayama University | REIC-expressing adenovirus vector |
| KR101466875B1 (ko) * | 2012-05-11 | 2014-12-03 | 가톨릭대학교 산학협력단 | 항종양괴사인자 수용체 2를 발현하도록 설계된 미니서클 벡터를 이용한 자가면역질환 치료 |
| KR101466874B1 (ko) * | 2012-05-11 | 2014-12-03 | 가톨릭대학교 산학협력단 | 자가면역 질환의 예방과 치료를 위한 ｉｌ-６ 수용체에 대한 항체를 발현하는 미니서클 |
| CA2929273C (en) | 2013-11-22 | 2022-05-31 | Amarna Holding B.V. | Method for restoring immune tolerance in vivo |
| EP3090263A4 (en) * | 2013-12-31 | 2017-08-23 | Yeda Research and Development Co., Ltd. | Methods for assaying immunological competence |
| WO2015101988A1 (en) | 2013-12-31 | 2015-07-09 | Yeda Research And Development Co. Ltd. | Diagnosis of systemic lupus erythematosus using oligonucleotides antigens |
| US12605432B2 (en) | 2014-06-04 | 2026-04-21 | Diamyd Medical Ab | Combinations for antigen based therapy |
| US20170196949A1 (en) * | 2014-06-04 | 2017-07-13 | Diamyd Medical Ab | Novel combinations for antigen based therapy |
| US11047855B2 (en) | 2015-03-01 | 2021-06-29 | Immunarray Ltd. | Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens |
| EP3472193A4 (en) * | 2016-06-20 | 2020-01-08 | The Board of Trustees of the Leland Stanford Junior University | CIRCULAR RNA AND THEIR USE IN IMMUNOMODULATION |
| PL3534936T3 (pl) | 2016-11-01 | 2021-01-25 | Novo Nordisk A/S | Szczepionka tolerogennego dna |
| SG11202012710WA (en) * | 2018-06-25 | 2021-01-28 | Akouos Inc | Methods of treating clrn1-associated hearing loss and/or vision loss |
| US11279745B2 (en) | 2019-04-26 | 2022-03-22 | Novo Nordisk A/S | Tolerogenic DNA vaccine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274136B1 (en) * | 1996-05-29 | 2001-08-14 | University Of Southern California | Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| AU4973199A (en) * | 1998-07-09 | 2000-02-01 | Merck & Co., Inc. | Polynucleotide vaccine formulations |
| CA2361421A1 (en) * | 1999-02-03 | 2000-08-10 | Biosante Pharmaceuticals, Inc. | Therapeutic calcium phosphate particles and methods of manufacture and use |
| US7030098B2 (en) * | 1999-03-12 | 2006-04-18 | The Board Of Trustees Of The Leland Stanford Junior University | DNA vaccination for treatment of autoimmune disease |
| US6479474B2 (en) * | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
| WO2003011118A2 (en) * | 2001-08-02 | 2003-02-13 | Trinity Biomedical Technology Corporation | Human zona pellucida proteins and methods of their use in diagnosing male infertility |
| EP2322185A3 (en) * | 2001-11-21 | 2011-08-10 | The Board Of Trustees Of The Leland Stanford Junior University | Polynucleotide therapy |
| CN1652770A (zh) * | 2002-03-29 | 2005-08-10 | 利兰·斯坦福青年大学托管委员会 | 使用抑制素和其它免疫调节剂治疗自身免疫病 |
| WO2005035771A2 (en) * | 2003-10-10 | 2005-04-21 | Powderject Vaccines, Inc. | Nucleic acid constructs |
-
2006
- 2006-10-04 JP JP2008534644A patent/JP2009511014A/ja active Pending
- 2006-10-04 US US12/089,190 patent/US20100160415A1/en not_active Abandoned
- 2006-10-04 CN CNA2006800456906A patent/CN101365494A/zh active Pending
- 2006-10-04 AU AU2006302477A patent/AU2006302477A1/en not_active Abandoned
- 2006-10-04 EP EP06825440A patent/EP1931390B1/en not_active Not-in-force
- 2006-10-04 CA CA002624615A patent/CA2624615A1/en not_active Abandoned
- 2006-10-04 NZ NZ567150A patent/NZ567150A/en not_active IP Right Cessation
- 2006-10-04 WO PCT/US2006/038776 patent/WO2007044394A2/en not_active Ceased
-
2008
- 2008-03-30 IL IL190520A patent/IL190520A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009511014A5 (https=) | ||
| Beaton et al. | The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release | |
| JP6272907B2 (ja) | 代謝障害の処置における組成物及び使用方法 | |
| Zhang et al. | Transcription and identification of an envelope protein gene (p22) from shrimp white spot syndrome virus | |
| JP2020514286A5 (https=) | ||
| IL319481A (en) | Variants of acid alpha-glucosidase and their uses | |
| JP2017512466A5 (https=) | ||
| JP2004024276A (ja) | 殺菌／浸透性が向上した安定なタンパク質生成物およびそれを含む薬剤組成物 | |
| JP2007297407A5 (https=) | ||
| CN108753824A (zh) | 用于治疗视网膜营养不良的病毒载体 | |
| JP2011501652A5 (https=) | ||
| CN114929735A (zh) | 因子viii构建体 | |
| JP2009523007A5 (https=) | ||
| WO2009031835A4 (en) | Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same | |
| JP2026034616A (ja) | 糖尿病を処置するための修飾型インスリンおよびグルコキナーゼ核酸 | |
| EP3943512A1 (en) | Fusion protein for enhancing gene editing and use thereof | |
| Tulalamba et al. | Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors | |
| Merle et al. | Perspectives for gene therapy of Wilson disease | |
| DE60336353D1 (de) | Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung | |
| JP2018536432A5 (https=) | ||
| JP2020535203A5 (https=) | ||
| Muramatsu et al. | Transcription-positive cofactor 4 enhances rescue of adeno-associated virus genome from an infectious clone | |
| WO2025076201A1 (en) | Human-targeted zinc finger protein to treat angelman syndrome | |
| WO2008125720A1 (es) | Vectores de expresión que comprenden el promotor del gen pklr humano y su uso para la elaboración de composiciones farmacéuticas destinadas a terapia génica somática con expresion específica en células eritroides | |
| Ishiwata et al. | Mutant macaque factor IX T262A: a tool for hemophilia B gene therapy studies in macaques |